BRAF and colorectal carcinoma: To assess whether this elevated rate of BRAF p.V600E mutations might be responsible for the increase in dMMR disease amongst the late-onset CRC population, the co-occurrence between BRAF p.V600E mutations and MMR deficiency was assessed.